Involvement of endogenous opioid peptides in the peripheral antinociceptive effect induced by the coffee specific diterpene kahweol

Pharmacological Reports

Volumn 67, Issue 5, 2015, Pages 1010-1015

  Guzzo, Luciana S ^a   Romero, Thiago R L ^a   Queiroz, Celso M ^a   Caliari, Marcelo V ^a   Azevedo, Adolfo O ^b   Perez, Andréa C ^a   Duarte, Igor D G ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNILAVRAS   (Brazil)

Author keywords

Coffee diterpene; Kahweol; Opioid system; Peripheral antinociception; Endorphin

Indexed keywords

BESTATIN; BETA ENDORPHIN; KAHWEOL; NALOXONE; OPIATE PEPTIDE; ANALGESIC AGENT; COFFEE; DITERPENE; LEUCINE; NARCOTIC ANTAGONIST; PEPTIDE; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; COFFEE; CONTROLLED STUDY; EPITHELIUM; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; PAIN THRESHOLD; PERIPHERAL ANTINOCICEPTION; PROTEIN EXPRESSION; RAT; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; METABOLISM; PAIN; PAIN MEASUREMENT; PRESSURE; SKIN; WISTAR RAT;

ANALGESICS; ANIMALS; BETA-ENDORPHIN; COFFEE; DINOPROSTONE; DITERPENES; HYPERALGESIA; LEUCINE; MALE; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID PEPTIDES; PAIN; PAIN MEASUREMENT; PEPTIDES; PRESSURE; RATS; RATS, WISTAR; SKIN;

EID: 84940046157     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2015.02.009     Document Type: Article

References (55)

1. J.V. Higdon, and B. Frei Coffee and health: a review of recent human research Crit Rev Food Sci Nutr 46 2 2006 101 126
2. G. Gross, E. Jaccaud, and A.C. Huggett Analysis of the content of the diterpenes cafestol and kahweol in coffee brews Food Chem Toxicol 35 6 1997 547 554
3. R. Urgert, and M.B. Katan The cholesterol-raising factor from coffee beans J R Soc Med 89 11 1996 618 623
4. R. Urgert, and M.B. Katan The cholesterol-raising factor from coffee beans Annu Rev Nutr 17 1997 305 324
5. C. Cavin, D. Holzhauser, A. Constable, A.C. Huggett, and B. Schilter The coffee-specific diterpenes cafestol and kahweol protect against aflatoxin B1-induced genotoxicity through a dual mechanism Carcinogenesis 19 8 1998 1369 1375
6. C. Cavin, D. Holzhaeuser, G. Scharf, A. Constable, W.W. Huber, and B. Schilter Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity Food Chem Toxicol 40 8 2002 1155 1163
7. H.G. Kim, Y.P. Hwang, and H.G. Jeong Kahweol blocks STAT3 phosphorylation and induces apoptosis in human lung adenocarcinoma A549 cells Toxicol Lett 187 1 2009 28 34
8. J.H. Oh, J.T. Lee, E.S. Yang, J.S. Chang, D.S. Lee, S.H. Kim, and et al. The coffee diterpene kahweol induces apoptosis in human leukemia U937 cells through down-regulation of Akt phosphorylation and activation of JNK Apoptosis 14 11 2009 1378 1386
9. H.J. Um, J.H. Oh, Y.-N. Kim, Y.H. Choi, S.H. Kim, J.-W. Park, and et al. The coffee diterpene kahweol sensitizes TRAIL-induced apoptosis in renal carcinoma Caki cells through down-regulation of Bcl-2 and c-FLIP Chem Biol Interact 186 1 2010 36 42
10. C. Cavin, K. Mace, E.A. Offord, and B. Schilter Protective effects of coffee diterpenes against aflatoxin B1-induced genotoxicity: mechanisms in rat and human cells Food Chem Toxicol 39 6 2001 549 556
11. W.W. Huber, W. Rossmanith, M. Grusch, E. Haslinger, S. Prustomersky, B. Peter-Vörösmarty, and et al. Effects of coffee and its chemopreventive components kahweol and cafestol on cytochrome P450 and sulfotransferase in rat liver Food Chem Toxicol 46 4 2008 1230 1238
12. W.W. Huber, S. Prustomersky, E. Delbanco, M. Uhl, G. Scharf, R.J. Turesky, and et al. Enhancement of the chemoprotective enzymes glucuronosyl transferase and glutathione transferase in specific organs of the rat by the coffee components kahweol and cafestol Arch Toxicol 76 4 2002 209 217
13. W.W. Huber, G. Scharf, G. Nagel, S. Prustomersky, R. Schulte-Hermann, and B. Kaina Coffee and its chemopreventive components Kahweol and Cafestol increase the activity of O6-methylguanine-DNA methyltransferase in rat liver-comparison with phase II xenobiotic metabolism Mutat Res Fund Mol Mech Mutagen 522 1-2 2003 57 68
14. W.W. Huber, C.H. Teitel, B.F. Coles, R.S. King, F.W. Wiese, K.R. Kaderlik, and et al. Potential chemoprotective effects of the coffee components kahweol and cafestol palmitates via modification of hepatic N-acetyltransferase and glutathione S-transferase activities Environ Mol Mutagen 44 4 2004 265 276
15. K.J. Lee, J.H. Choi, and H.G. Jeong Hepatoprotective and antioxidant effects of the coffee diterpenes kahweol and cafestol on carbon tetrachloride-induced liver damage in mice Food Chem Toxicol 45 11 2007 2118 2125
16. K.J. Lee, and H.G. Jeong Protective effects of kahweol and cafestol against hydrogen peroxide-induced oxidative stress and DNA damage Toxicol Lett 173 2 2007 80 87
17. H.P. Hwang, and H.G. Jeong The coffee diterpene kahweol induces heme oxygenase-1 via the PI3K and p38/Nrf2 pathway to protect human dopaminergic neurons from 6-hydroxydopamine-derived oxidative stress FEBS Lett 582 17 2008 2655 2662
18. J.Y. Kim, D.H. Kim, and H.G. Jeong Inhibitory effect of the coffee diterpene kahweol on carrageenan-induced inflammation in rats Biofactors 26 1 2006 17 28
19. H.G. Kim, J.Y. Kim, Y.P. Hwang, K.J. Lee, K.Y. Lee, D.H. Kim, and et al. The coffee diterpene kahweol inhibits tumor necrosis factor-alpha-induced expression of cell adhesion molecules in human endothelial cells Toxicol Appl Pharmacol 217 3 2006 332 341
20. J.Y. Kim, K.S. Jung, and H.G. Jeong Suppressive effects of the kahweol and cafestol on cyclooxygenase-2 expression in macrophages FEBS Lett 569 1-3 2004 321 326
21. J.Y. Kim, K.S. Jung, K.J. Lee, H.K. Na, H.K. Chun, Y.H. Kho, and et al. The coffee diterpene kahweol suppress the inducible nitric oxide synthase expression in macrophages Cancer Lett 213 2 2004 147 154
22. S.H. Ferreira, and M. Nakamura II - Prostaglandin hyperalgesia, the peripheral analgesic activity of morphine, enkephalin and opioid antagonists Prostaglandins 18 2 1979 191 200
23. L.S. Guzzo, A.C. Perez, T.R.L. Romero, A.O. Azevedo, and I.D.G. Duarte Cafestol, a coffee-specific diterpene, induces peripheral antinociception mediated by endogenous opioid peptides Clin Exp Pharmacol Physiol 39 5 2012 412 416
24. D.S. França, D.L. Ferreira-Alves, I.D. Duarte, M.C. Ribeiro, R.M. Rezende, Y.S. Bakhle, and et al. Endogenous opioids mediate the hypoalgesia induced by inhibitors of cyclooxygenase-2 in rat paws treated with carrageenan Neuropharmacology 51 1 2006 37 43
25. M. Nakamura, and H.S. Ferreira Peripheral analgesic action of clonidine: mediation by release of endogenous enkephalin-like substances Eur J Pharmacol 146 2-3 1988 223 228
26. M. Nakamura, and M.C. Lico Peripheral modulation of pain in conscious guinea pigs: effect of morphine, nalorphine and clonidine Braz J Med Biol Res 21 3 1988 577 583
27. T.R.L. Romero, A.C. Perez, J.N. Francischi, and I.D.G. Duarte Probable involvement of α2C-adrenoceptor subtype and endogenous opioid peptides in the peripheral antinociceptive effect induced by xylazine Eur J Pharmacol 608 1-3 2009 23 27
28. A. Khodorova, M.U. Fareed, A. Gokin, G.R. Strichartz, and G. Davar Local injection of a selective endothelin-B receptor agonist inhibits endothelin-1-induced pain-like behavior and excitation of nociceptors in a naloxone-sensitive manner J Neurosci 22 17 2002 7788 7796
29. P.N. Quang, and B.L. Schmidt Peripheral endothelin B receptor agonist-induced antinociception involves endogenous opioids in mice Pain 149 2 2010 254 262
30. A.F. Green, and P.A. Young A comparison of heat and pressure analgesiometric methods in rats Br J Pharmacol 6 4 1951 572 585
31. L.O. Randall, and J.J. Sellito A method for measurement of analgesic activity on inflamed tissues Arch Int Pharmacodyn Ther 111 4 1957 409 419
32. 2 and pain - an update Biol Pharm Bull 34 8 2011 1170 1173
33. R. Vinegar, J.F. Truax, J.L. Selph, P.R. Johnston, A.L. Venable, and K.K. McKenzie Pathway to carrageenan-induced inflammation in the hind limb of the rat Fed Proc 46 1 1987 118 126
34. 2 Prostaglandins 16 1 1978 31 37
35. D.P. Alves, P.G. da Motta, P.P. Lima, C.M. Queiroz-Junior, M.V. Caliari, D.F. Pacheco, and et al. Inflammation mobilizes local resources to control hyperalgesia: the role of endogenous opioid peptides Pharmacology 89 1-2 2012 22 28
36. S. Fürst Transmitters involved in antinociception in the spinal cord Brain Res Bull 48 2 1999 129 141
37. M.J. Millan Descending control of pain Prog Neurobiol 66 6 2002 335 474
38. H.S. Smith Peripherally-acting opioids Pain Physician 11 2 2008 S121 S132
39. C. Stein, M. Schäfer, and H. Machelska Attacking pain at its source: new perspectives on opioids Nat Med 9 8 2003 1003 1008
40. M.-R. Jia, T. Wei, and W.-F. Xu The analgesic activity of Bestatin as a potent APN inhibitor Front Neurosci 4 2010 1 10
41. M.M. Ibrahim, F. Porreca, J. Lai, P.J. Albrecht, F.L. Rice, A. Khodorova, and et al. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids PNAS 102 8 2005 3093 3098
42. S. Kauser, K. Schallreuter, A. Thody, C. Gummer, and D. Tobin Regulation of human epidermal melanocyte biology by beta-endorphin J Invest Dermatol 120 6 2003 1073 1080
43. A. Khodorova, B. Navarro, L.S. Jouaville, J.E. Murphy, F.L. Rice, J.E. Mazurkiewicz, and et al. Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury Nat Med 9 8 2003 1055 1061
44. M. Bigliardi-Qi, L.T. Sumanovski, S. Büchner, T. Rufli, and P.L. Bigliardi Mu-opiate receptor and beta-endorphin expression in nerve endings and keratinocytes in human skin Dermatology 209 3 2004 183 189
45. E. Schauer, F. Trautinger, A. Köck, A. Schwarz, R. Bhardwaj, M. Simon, and et al. Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes J Clin Invest 93 5 1994 2258 2262
46. M. Wintzen, M. Yaar, P. Burbach, and B. Gilchrest Proopiomelanocortin gene product regulation in keratinocytes J Invest Dermatol 106 4 1996 673 678
47. C. Stein, A.H. Hassan, R. Przewłocki, C. Gramsch, K. Peter, and A. Herz Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation Proc Natl Acad Sci USA 87 15 1990 5935 5939
48. H.L. Rittner, A. Brack, H. Machelska, S.A. Mousa, M. Bauer, M. Schäfer, and et al. Opioid peptide expressing leukocytes: identification, recruitment and simultaneously increasing inhibition of inflammatory pain Anesthesiology 95 2 2001 500 508
49. P.J. Cabot, L. Carter, C. Gaiddon, Q. Zhang, M. Schäfer, J.P. Loefflerm, and et al. Immune cell-derived β-endorphin: production, release and control of inflammatory pain in a rats J Clin Invest 100 1 1997 142 148
50. S.A. Mousa, M. Shakibaei, N. Sitte, M. Schäfer, and C. Stein Subcellular pathways of β-endorphin synthesis, processing, and release from immunocytes in inflammatory pain Endocrinology 145 3 2004 1331 1341
51. R. Przewłocki, A.H. Hassan, W. Lason, C. Epplen, A. Herz, and C. Stein Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception Neuroscience 48 2 1992 491 500
52. H. Vanegas, and H. Schaible Prostaglandins and cicloxygenase in the spinal cord Prog Neurobiol 64 4 2001 327 363
53. 2+-regulated release of opioid peptides from polymorphonuclear cells FASEB J 20 14 2006 2627 2629
54. H.L. Fields, P.C. Emson, B.K. Leigh, R.F. Gilbert, and L.L. Iversen Multiple opiate receptors sites on primary afferent fibers Nature 284 5754 1980 351 353
55. C. Stein, and L.J. Lang Peripheral mechanisms of opioid analgesia Curr Opin Pharmacol 9 1 2009 3 8